PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne ...
Learn how a Declaration of Conformity (DoC) is intended to ensure product safety and legal compliance, and explore its key ...
Los Angeles Employment Lawyers Help Workers Navigate 2026 Wage Theft, Discrimination, and Wrongful Termination Claims Under New California Labor Laws LOS ANGELES, CA, UNITED STATES, February 4, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results